Director, Global Value & Access Strategy (Endocrinology))
Vertex Pharmaceuticals - Boston, MA
Posted Jun 21, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Offered From the posting source checked Nov 18, 2026
- Verification
- Not verified
- Salary
- $212K-$318K From the posting source checked Nov 18, 2026
- 401(k) match
- Not verified
Was this benefit information wrong? Tell us.
Role
- Seniority
- Director Plus From the posting source checked Nov 18, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 18, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Director, Global Value & Access Strategy (Endocrinology)) Boston, MA Job Description Title: Director, Global Value & Access Strategy (Endocrinology) Background and Job Description: Vertex operates at the forefront of scientific innovation and has successfully developed and commercialized multiple breakthrough medicines for Cystic Fibrosis (CF) as well as CASGEVY, a gene therapy for sickle cell disease and beta-thalassemia, and JOURNAVX, a first-in-class treatment for moderate-to-severe acute pain. Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases including programs in B cell mediated renal diseases, APOL-1 mediated kidney disease (AMKD), chronic pain and DM-1, and cell therapies for Type 1 diabetes, among others. Overview: Market Access is a key commercial function that ensures transformative Vertex therapies are appropriately funded and ultimately make it into the hands of the patients around the world. The Global Value & Access Strategy (GVAS) team works cross-functionally and across regions to ensure the payer view is represented in commercial and development plans across the lifecycle. We are driven by a desire to deliver groundbreaking pricing & reimbursement solutions to allow our medicines to reach patients faster than ever before. The Director, Endocrinology role will focus on the assets atumelnant and Palsonify (paltusotine). The individual will be responsible to ensure global access launch readiness for atumelnant as a potential first-in-class therapy for the potential treatment of Congenital Adrenal Hyperplasia (CAH). Additionally, the individual will provide targeted global P&MA support for the commercialization of Palsonify (paltusotine) for the treatment of
Read the full description at vrtx.wd501.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Senior Director, Global Market Access
Cogent Biosciences Inc - Waltham, Massachusetts, United States
Medical Director, Endocrinology
Vertex Pharmaceuticals - Boston, MA
National Director, Regional Access Team
Amylyx Pharmaceuticals Inc - Cambridge, MA
Director of Rare Disease Market Access Strategy
Biogen - Cambridge, MA